相关实验视频

Updated: Jul 19, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

在癌症免疫治疗中,一个新兴的新目标:加列-9 (LGALS9)

Yan Lv¹, Xiao Ma², Yuxin Ma¹

¹The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China.

Genes & diseases

|August 9, 2023

概括

免疫检查点抑制剂,如加勒-9 (LGALS9),正在彻底改变癌症免疫疗法. 向galectin-9显示,它有望刺激抗瘤免疫反应并改善癌症患者的预后.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症免疫疗法癌症免疫疗法

背景情况:

免疫学的进步已经确定了新的免疫检查点,增强了癌症免疫疗法.
免疫检查点抑制剂现在是领先的精确癌症治疗方法.
加列-9 (LGALS9) 是一种加列家族成员,在免疫调节和瘤发病过程中发挥作用,影响癌症预后.

研究的目的:

审查加勒-9及其受体Tim-3的信号机制和免疫调节活性.
总结各种恶性瘤中加勒-9的表达模式.
探索抗质素-9疗法在增强抗瘤免疫力方面的潜力.

主要方法:

关于加勒-9和Tim-3信号的文献综述.
对不同癌症中的加勒-9表达数据的分析.
对抗甲-9疗法的临床前和临床研究的审查.

主要成果:

加勒-9与Tim-3相互作用,调节免疫恒温和瘤细胞存活率.
加勒-9在许多恶性瘤中表现出有针对性的表达模式.
抗质素-9的策略显示了激活抗瘤免疫反应的潜力.

结论:

加勒-9是癌症免疫调节和发病的一个重要因素.
准加勒-9/蒂姆-3轴为癌症免疫治疗提供了一个有前途的治疗策略.
进一步研究抗银素-9疗法可能会导致改善癌症治疗结果.

关键词:

盖莱克-9 是一种蛋白质.免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.单克隆抗体是一种单克隆抗体.蒂姆-3的时间.

更多相关视频

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Selectins

Selectins

Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...